Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Zishen Huoxue Fang is a Traditional Chinese Medicine (TCM) formula designed to supplement Qi, nourish the kidney, and activate blood circulation. It is primarily utilized in the treatment of chronic kidney diseases (CKD), including diabetic nephropathy and IgA nephropathy. The formula typically consists of a combination of botanical ingredients such as *Astragalus membranaceus* (Huangqi), *Rehmannia glutinosa* (Dihuang), and *Salvia miltiorrhiza* (Danshen). Mechanistically, it is reported to exert therapeutic effects by inhibiting renal fibrosis and inflammation, specifically through the modulation of the TGF-beta1/Smad signaling pathway and the reduction of inflammatory mediators like NF-kappaB. Clinical and preclinical studies suggest its efficacy in reducing proteinuria and improving overall renal function in patients with chronic renal impairment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yiqi zishen huoxue fang.